Oxea's Q4 net income up 56% on higher sales, improved margins

25 February 2013 11:53  [Source: ICIS news]

LONDON (ICIS)--Oxea’s fourth-quarter 2012 net income rose by 56% to €14.4m ($18.9m) due to a higher operating profit and lower net financial expense, the global oxo chemicals firm said on Monday.

Net sales for the three months ended 31 December 2012 were €342.9m, an increase of 4.4% compared with the corresponding period of the prior year, as overall volumes grew 2.6%. Oxo Intermediates volumes were up by 1.7% and Oxo Derivatives volumes traded 5.9% higher, it added.

“The increase in revenues and earnings can be recognised across the entire product portfolio and all regions,” the company said.

Oxea said €158m of it revenues resulted from sales in Europe, €115m in North America, and €69m in the rest of the world compared with €141m, €109m, and €78m, respectively, in the prior year period.

Operating profit for the fourth quarter was €43.2m compared with €31.7m in the corresponding period the year before, primarily as a result of lower selling, general and administration expenses and higher gross profit – which rose 38% year on year to €47.1m on higher sales and improved margins.

On a full year basis, revenues of €1.46bn were slightly below the previous year, falling 1.4%, on the back of a soft world economy and overall challenging macroeconomic conditions, while net profit in 2012 fell 9.4% to €69.8m.

($1 = €0.76)

By: Franco Capaldo
+44 (0)20 8652 3214

AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly